menu
    • menu

    Company profile for Cogent Biosciences

    NEW Drugs in Dev: 6
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, we are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients. Millions of people around the world are living with a genetically defined disease. Mutations can create a ripple effect in the body to tr...
    Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, we are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients. Millions of people around the world are living with a genetically defined disease. Mutations can create a ripple effect in the body to trigger illness – cancers, autoimmune conditions, and rare diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cogent BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Cambridge Park Drive, Suite 2500 Cambridge, MA 02140
    Telephone
    Telephone
    617.945.5576
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cogentbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cogentbiosciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CogentBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Accepts Cogent's Bezuclastinib NDA for Non-AdvSM Mastocytosis
    FDA Accepts Cogent's Bezuclastinib NDA for Non-AdvSM Mastocytosis

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256200/0/en/Cogent-Biosciences-Announces-FDA-Acceptance-of-New-Drug-Application-for-Bezuclastinib-in-Patients-with-NonAdvanced-Systemic-Mastocytosis-NonAdvSM.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Cogent Biosciences to Highlight Bezuclastinib Posters at AAAAI
    Cogent Biosciences to Highlight Bezuclastinib Posters at AAAAI

    28 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/28/3246892/0/en/Cogent-Biosciences-Highlights-Additional-Data-with-Six-Bezuclastinib-Posters-from-SUMMIT-Trial-at-2026-AAAAI-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Feb 2026
    Share Share
    Cogent Biosciences Reports 2025 Results and Business Highlights
    Cogent Biosciences Reports 2025 Results and Business Highlights

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239198/0/en/Cogent-Biosciences-Reports-Recent-Business-Highlights-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Cogent Bio Presents Multiple SUMMIT Posters At AAAAI 2026
    Cogent Bio Presents Multiple SUMMIT Posters At AAAAI 2026

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235231/0/en/Cogent-Biosciences-Announces-Multiple-SUMMIT-Posters-at-the-2026-AAAAI-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Cogent’s Bezuclastinib Combo Gains FDA Breakthrough Status
    Cogent’s Bezuclastinib Combo Gains FDA Breakthrough Status

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225587/0/en/Cogent-Biosciences-Announces-Breakthrough-Therapy-Designation-for-Bezuclastinib-in-Combination-with-Sunitinib-for-Patients-with-Gastrointestinal-Stromal-Tumors-GIST.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Cogent Biosciences Files NDA for Bezuclastinib Under RTOR
    Cogent Biosciences Files NDA for Bezuclastinib Under RTOR

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221679/0/en/Cogent-Biosciences-to-Initiate-New-Drug-Application-NDA-Submission-for-Bezuclastinib-Under-Real-Time-Oncology-Review-RTOR.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search